Golden Green, Inc. Zai Lab LTD Transaction History

Golden Green, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$54.9 - $105.21 $137,469 - $263,445	-2,504 Closed	0 $0
Q3 2021 Oct 08, 2021	SELL	$105.0 - $178.37 $74,865 - $127,177	-713 Reduced 22.16%	2,504 $264,000
Q2 2021 Jul 14, 2021	BUY	$125.11 - $180.0 $23,145 - $33,300	185 Added 6.1%	3,217 $569,000
Q1 2021 Apr 13, 2021	BUY	$126.27 - $191.71 $382,850 - $581,264	3,032 New	3,032 $405,000

123

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.55B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.